CleanTech Biofuels, Inc. - Quarter Report: 2008 March (Form 10-Q)
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2008
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR |
THE TRANSITION PERIOD FROM TO
Commission file number 333-145939
CLEANTECH BIOFUELS, INC.
(Exact name of registrant as specified in its charter)
Delaware | 33-0754902 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
7386 Pershing Ave., University City, Missouri | 63130 | |
(Address of principal executive offices) | (Zip Code) |
(Registrants telephone number): (314) 802-8670
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. YES þ NO o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer o | Accelerated filer o | Non-accelerated filer o | Smaller reporting company þ | |||
(Do not check if a smaller reporting company) |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No þ
As of May 12, 2008, 61,120,278 shares of the Companys common stock were outstanding.
CLEANTECH BIOFUELS, INC.
TABLE OF CONTENTS
TABLE OF CONTENTS
PAGE | ||||||||
1 | ||||||||
1 | ||||||||
1 | ||||||||
2 | ||||||||
3 | ||||||||
4 | ||||||||
5 | ||||||||
10 | ||||||||
14 | ||||||||
15 | ||||||||
15 | ||||||||
15 | ||||||||
15 | ||||||||
16 | ||||||||
16 | ||||||||
16 | ||||||||
16 | ||||||||
16 | ||||||||
17 | ||||||||
18 | ||||||||
Exhibit 31.1 | ||||||||
Exhibit 31.2 | ||||||||
Exhibit 32.1 | ||||||||
Exhibit 32.2 |
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
BALANCE SHEET
March 31, 2008 | December 31, | |||||||
(unaudited) | 2007 | |||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 297,590 | $ | 120,356 | ||||
Receivables: |
||||||||
Interest |
| 19,425 | ||||||
Promissory notes |
| 450,000 | ||||||
Prepaids and other current assets |
60,445 | 72,026 | ||||||
358,035 | 661,807 | |||||||
Property and equipment, net |
38,989 | 3,099 | ||||||
Non-current asset: |
||||||||
Technology license, net |
108,750 | 112,500 | ||||||
Total Assets |
$ | 505,774 | $ | 777,406 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 163,526 | $ | 91,988 | ||||
Accrued interest |
44,917 | 60,433 | ||||||
Accrued professional fees |
36,600 | 36,600 | ||||||
Capital Lease |
4,508 | | ||||||
Total current liabilities |
249,551 | 189,021 | ||||||
Capital Lease |
9,245 | | ||||||
Series A Convertible Debentures |
770,000 | 1,400,000 | ||||||
STOCKHOLDERS DEFICIT |
||||||||
Preferred stock, $0.001 par value; 10,000,000 authorized shares; no
shares issued or outstanding |
| | ||||||
Common stock, $0.001 par value; 240,000,000 authorized shares; 53,776,747
and 49,343,680 shares issued and outstanding at March 31, 2008 and
December 31, 2007, respectively |
53,777 | 49,344 | ||||||
Additional paid-in capital |
1,610,706 | 364,260 | ||||||
Notes receivable restricted common shares issued to Directors |
(90,000 | ) | (90,000 | ) | ||||
Deficit accumulated during the development stage |
(2,097,505 | ) | (1,135,219 | ) | ||||
Total Stockholders Deficit |
(523,022 | ) | (811,615 | ) | ||||
Total Liabilities and Stockholders Deficit |
$ | 505,774 | $ | 777,406 | ||||
See accompanying notes to financial statements.
1
Table of Contents
CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
STATEMENTS OF OPERATIONS (unaudited)
July 14, 2004 | ||||||||||||
Three months ended | (inception) to | |||||||||||
March 31, | March 31, | |||||||||||
2008 | 2007 | 2008 | ||||||||||
Costs and expenses: |
||||||||||||
General and administrative |
$ | 649,462 | $ | 4,007 | $ | 1,149,097 | ||||||
Professional fees |
111,946 | 1,970 | 440,589 | |||||||||
Research and development |
183,104 | | 315,334 | |||||||||
944,512 | 5,977 | 1,905,020 | ||||||||||
Other expense (income): |
||||||||||||
Interest |
19,751 | 3,597 | 86,519 | |||||||||
Amortization of technology license |
3,750 | | 23,750 | |||||||||
Deposit forfeiture |
| | (25,000 | ) | ||||||||
Interest income |
(5,727 | ) | | (27,132 | ) | |||||||
17,774 | 3,597 | 58,137 | ||||||||||
Net loss applicable to common stockholders |
$ | 962,286 | $ | 9,574 | $ | 1,963,157 | ||||||
Basic and diluted net loss per common share |
$ | 0.02 | ** | $ | 0.05 | |||||||
Weighted average common shares outstanding |
50,082,525 | 38,624,784 | 41,107,993 | |||||||||
** | - less than $.01 per share |
See accompanying notes to financial statements.
2
Table of Contents
CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
Statements of Changes in Stockholders Deficit (unaudited)
Notes Rec - | ||||||||||||||||||||
restricted | ||||||||||||||||||||
common | July 14, 2004 | |||||||||||||||||||
Additional | shares | (inception) to | ||||||||||||||||||
Common Stock | Paid-in | issued to | March 31, | |||||||||||||||||
Shares | Amount | Capital | Directors | 2008 | ||||||||||||||||
Balances at December 31, 2007 |
49,343,680 | $ | 49,344 | $ | 364,260 | $ | (90,000 | ) | $ | (1,135,219 | ) | |||||||||
Conversion of promissory notes in March 2008
at $.15 per share |
4,433,067 | 4,433 | 660,527 | |||||||||||||||||
Stock-based compensation |
585,919 | |||||||||||||||||||
Net loss |
(962,286 | ) | ||||||||||||||||||
Balances at March 31, 2008 |
53,776,747 | $ | 53,777 | $ | 1,610,706 | $ | (90,000 | ) | $ | (2,097,505 | ) | |||||||||
See accompanying notes to financial statements.
3
Table of Contents
CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
STATEMENTS OF CASH FLOWS (unaudited)
July 14, 2004 | ||||||||||||
For the three months ended | (inception) to | |||||||||||
March 31, | March 31, | |||||||||||
2008 | 2007 | 2008 | ||||||||||
OPERATING ACTIVITIES |
||||||||||||
Net loss applicable to common stockholders |
$ | (962,286 | ) | $ | (9,574 | ) | $ | (1,963,157 | ) | |||
Adjustments to reconcile net loss applicable to common
stockholders to net cash used by operating activities: |
||||||||||||
Common stock issued for organizational costs |
| | 100 | |||||||||
Amortization |
3,750 | | 23,750 | |||||||||
Depreciation |
4,909 | | 5,165 | |||||||||
Share-based compensation expense |
585,919 | | 625,048 | |||||||||
Fair value of RAM warrant settlement |
| | 125,027 | |||||||||
Changes in operating assets and liabilities: |
||||||||||||
Interest receivable |
(5,475 | ) | | | ||||||||
Prepaids and other current assets |
11,581 | | (60,445 | ) | ||||||||
Technology license |
| (15,000 | ) | (132,500 | ) | |||||||
Accounts payable |
71,538 | | 163,526 | |||||||||
Accrued interest |
19,444 | 3,027 | 54,977 | |||||||||
Accrued liabilities |
| 1,971 | 36,600 | |||||||||
Cash used by operating activities |
(270,620 | ) | (19,576 | ) | (1,121,909 | ) | ||||||
INVESTING ACTIVITIES |
||||||||||||
Expenditures for equipment |
(40,799 | ) | | (44,154 | ) | |||||||
Cash used by investing activities |
(40,799 | ) | | (44,154 | ) | |||||||
FINANCING ACTIVITIES |
||||||||||||
Advances related parties |
| 19,576 | | |||||||||
Capital lease |
13,753 | | 13,753 | |||||||||
Series A Convertible Debentures |
474,900 | | 1,424,900 | |||||||||
Sale of common stock |
| | 25,000 | |||||||||
Cash provided by financing activities |
488,653 | 19,576 | 1,463,653 | |||||||||
Increase (decrease) in cash and cash equivalents |
177,234 | | 297,590 | |||||||||
Cash and cash equivalents at beginning of period |
120,356 | 20 | | |||||||||
Cash and cash equivalents at end of period |
$ | 297,590 | $ | 20 | $ | 297,590 | ||||||
Supplemental disclosure of cash flow information: |
||||||||||||
Cash paid for interest |
$ | | $ | | $ | 6,334 | ||||||
Supplemental disclosure of noncash investing and
financing activities: |
||||||||||||
Promissory notes receivable |
$ | | $ | | $ | 450,000 | ||||||
Series A Convertible Debentures |
$ | | $ | | $ | 450,000 | ||||||
Restricted common stock issued to Directors |
$ | | $ | | $ | 90,000 | ||||||
Common stock issued for organizational costs |
$ | | $ | | $ | 100 | ||||||
Common stock issued for promissory notes |
$ | | $ | | $ | 133,596 | ||||||
Common stock issued for Debentures converted |
$ | 664,960 | $ | | $ | 664,960 | ||||||
See accompanying notes to financial statements.
4
Table of Contents
Note 1 Organization and Business
Alternative Ethanol Technologies, Inc. (the Company), was incorporated in Delaware on December
20, 1996. Effective August 2, 2007, the Company changed its name to CleanTech Biofuels, Inc.
On March 27, 2007, the Company acquired SRS Energy, Inc., a Delaware corporation (SRS Energy),
pursuant to an Agreement and Plan of Merger and Reorganization. In accordance with the merger
agreement, SRS Acquisition Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the
Company, merged with and into SRS Energy. The merger was consummated on May 31, 2007 and resulted
in SRS Energy becoming a wholly-owned subsidiary of the Company. As a result of the merger, the
stockholders of SRS Energy surrendered all of their issued and outstanding common stock and
received shares of the Companys $.001 par value common stock. The former parent of SRS Energy,
Supercritical Recovery Systems, Inc., immediately prior to the merger, distributed 78.8% of its 96%
ownership in SRS Energy to its shareholders on a pro rata basis.
For accounting purposes, because the Company had been a public shell company prior to the merger,
the merger was treated as an acquisition of the Company and a recapitalization of SRS Energy. As a
result, the historical information of the Company prior to the merger disclosed in this report is
that of SRS Energy. In addition, historical share amounts have been restated to reflect the effect
of the merger.
The Company is a development stage company that has been engaged in technology development and
pre-operational activities since its formation. Its business strategy is to develop, own and
operate renewable energy facilities with a primary focus on the conversion of cellulose feed stocks
to fuel ethanol and other combustible fuels. The Company has limited exclusive licenses to
technology designed to convert cellulosic feed stocks, including municipal solid waste (also
referred to as MSW), into ethanol and other combustible sources of energy. The Company has no
operating history as a producer of ethanol and has not constructed any ethanol plants to date. It
has no revenues to date and expects that its current capital and other existing resources will be
sufficient only to provide a limited amount of working capital. The Company will require
substantial additional capital to implement our business plan and it may be unable to obtain the
capital required to do so.
Note 2 Interim Financial Statements
The accompanying unaudited, financial statements have been prepared in accordance with accounting
principles generally accepted in the United States for interim financial information and with the
instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of
the information and notes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments, consisting of normal recurring
items considered necessary for a fair presentation, have been included. Operating results for the
three months ended March 31, 2008 are not necessarily indicative of the results that may be
expected for the year ended December 31, 2008. For further information, refer to the Companys
audited financial statements and notes thereto included in our Annual Report on Form 10-KSB for the
year ended December 31, 2007, filed with the Securities and Exchange Commission on March 28, 2008.
Note 3 Technology Licenses
On April 1, 2005, the Company entered into an exclusive license with Brelsford Engineering,
Inc. (Brelsford) to use their technology (Patent No. 5,411,594) to convert
cellulosic biomass into fuel grade ethanol in the United States. This agreement was amended in
November 2005 to extend the initial evaluation period for the technology.
Under the terms of the license with Brelsford, the Company paid an initial fee of $50,000 and
monthly fees for the trial option premium totaling $67,500 (recorded as a long-term asset in the
aggregate on the balance sheet). The Company also pays a minimum annual fee of $15,000 and a
project fee of $30,000 for each project that commences for the manufacture of a plant. On August
30, 2007, the Company paid the first project fee in the amount of $30,000 to Brelsford with the
respect to the commencement of the design of our pilot plant and Brelsford simultaneously
acknowledged that the Company has met all requirements to maintain the exclusivity of its license.
In addition, the Company will pay a royalty fee equal to 4 percent of sales resulting from use of
the licensed product less any applicable taxes. Brelsford may terminate the license agreement on
sixty days notice if the Company fails to make
any payment due under our license agreement. Commencing with the first project payment, the Company
began amortizing costs previously capitalized over the remaining term of the license. Amortization
expense for the three month period ended March 31, 2008 is $3,750. There was no amortization
expense for the three months ended March 31, 2007. The license, issued to Brelsford, terminates
simultaneously with the expiration of the patent, in May 2015.
5
Table of Contents
On August 17, 2005, the Company entered into an exclusive license agreement with Bio-Products
International, Inc. (Bio-Products) giving it limited exclusive rights to use Bio-Products
technology (Patent No. 6,306,248) to process MSW and convert the cellulosic component of that waste
to a homogenous feedstock to produce ethanol in the United States, subject to the right of
Bio-Products to request five sites to construct garbage to ethanol plants in the United States.
The Companys license with Bio-Products is for a period of twenty years. Under the license,
Bio-Products is paid a process royalty of $1.50 for every ton of waste received and processed at
each facility to be constructed and operated under the agreement. The Company also is required to
pay a by-product royalty of 2.5 percent of the gross sales price in excess of ten dollars per ton
obtained from the sale of recyclable byproducts, excluding the cellulosic biomass. Bio-Products
will also be paid a monthly fee for technical services to be provided by Bio-Products for each
facility to be constructed and operated which initially will be $10,000 per month and will increase
to $20,000 per month when vessels for processing waste are ordered for the facility. The $20,000
per month fee continues until construction of the facility is completed.
On March 20, 2008, the Company entered into an agreement for an exclusive worldwide license with
HFTA, Inc. (HFTA) to use the HFTA technology for the production of ethanol from MSW. The terms
set out in the agreement required us to pay an initial license fee of $25,000 to HFTA on execution
of the agreement and a second license fee in the amount of $150,000 on September 1, 2009 if we are
using the technology at that time. Additionally, we deposited 2,887,687 shares of our common stock
into an escrow account on May 12, 2008. The shares held in escrow will be released to HFTA as
follows: one-third upon completion of the proof of concept phase if at that time we elect to
continue to use the HFTA technology in the demonstration phase and two-thirds upon completion of
the demonstration phase if at that time we elect to incorporate the HFTA technology into the small
commercial plant. In addition, we are required to pay a process royalty of 4% of the sales price of
ethanol less taxes and applicable fees if the sales price is in excess of $1.50 per gallon, 3% of
the sales price if it is between $1.50 and $1.30 per gallon, and 2% of the sales price if it is
less than $1.30 per gallon. We are also required to pay certain minimum royalties, less the amount
of any process royalties paid, commencing in the calendar year ending December 31, 2010 and in
subsequent years as follows: (i) 2010 -$25,000; (ii) 2011 $25,000; (iii) 2012 $60,000; (iv)
increasing by $20,000 per year for each year thereafter until it reaches $120,000 per year; and (v)
$120,000 per year thereafter.
Intangible assets are reviewed for impairment whenever events or other changes in circumstances
indicate that the carrying amount may not be recoverable. An impairment charge is recognized if the
carrying amount of an intangible asset exceeds its implied fair value.
Note 4 Series A Convertible Debentures
In April 2007, the Company sold $1,400,000 of Series A Convertible Debentures (Debentures), due
April 16, 2010, that convert into shares of the Companys common stock at $.15 per share. The
Company filed a registration statement with regard to the sale of these shares of common stock,
which was declared effective by the Securities and Exchange Commission on January 2, 2008. The
debentures accrue interest at 6% per annum. The interest is payable in cash or shares of the
Companys common stock at the Companys option. The Debenture Holders can convert their amount into
shares at any time until the due date. The maximum number of shares that would be issued at the due
date is 11,013,333.
The Company received cash of $950,000 and Promissory Notes (Notes) with an aggregate principal
amount of $450,000 that accrue interest at 6.0%. Effective with the listing of our common stock on
the OTCBB on March 13, 2008 (previously traded on Pink Sheets) we received the $450,000 plus
approximately $25,000 in interest on the Notes on March 14, 2008.
6
Table of Contents
From March 13, 2008 through March 19, 2008, various debenture holders converted an aggregate amount
of $630,000 of our debentures, plus interest earned, into 4,433,067 shares of our common stock. See
the Subsequent Events footnote for information regarding additional conversions that occurred after
March 31, 2008.
Note 5 Stockholders Deficit
In May 2007, the Company acquired SRS Energy through a reverse merger. Pursuant to the merger, the
Company issued 38,624,784 shares of the Companys common stock and a warrant exercisable until
August 31, 2009 to purchase 1,923,495 shares of common stock at $.13 per share to the former
stockholders of SRS Energy in exchange for the cancellation of all of the outstanding capital stock
of SRS Energy and cancellation of an option to acquire 5% of the outstanding capital stock of SRS
Energy. The Company affected a reverse split of its common stock at a ratio of 100 to 1 in January
2007. For accounting purposes, because the Company had been a public shell company prior to the
merger, the merger was treated as an acquisition of the Company and a recapitalization of SRS
Energy. As such, the historical information prior to the merger of the Company disclosed in the
report is that of SRS Energy. Historical share amounts have been restated to reflect the effect of
the merger.
In May 2007, the Company issued 9,366,800 shares of common stock ($.014 per share) upon the
conversion of three promissory notes totaling $114,681 and accrued interest of $18,915.
In March 2008, the Company issued 4,433,067 shares of common stock ($0.15 per share) upon the
conversion of an aggregate amount of $630,000 of the Companys Series A Convertible Debentures and
accrued interest of $34,960.
Note 6 Related Party Transactions
For the three months ended March 31, 2008 and 2007, the Company incurred corporate and
administrative fees of approximately $350 and $4,000, respectively, for expenses paid by its
president on behalf of the Company. The Company had been using the office of its president for
corporate and administrative purposes until entering into a lease for office space which we
occupied and began paying rent in January 2008.
The Company had a $72,103 advance from one of its board of director members at December 31, 2006
evidenced by a promissory note that accrued interest at 9.5% per annum. The promissory note also
contained an option to acquire 5% of the outstanding capital stock of SRS Energy at a price of
$250,000. In April 2007, the indebtedness under the promissory note was repaid and the promissory
note was cancelled. Under its terms, the right to exercise the option to purchase shares survived
after the repayment of the indebtedness under the note. As part of the merger consideration issued
by the Company pursuant to the acquisition of SRS Energy, the Company issued a warrant exercisable
until August 31, 2009 to purchase 1,923,495 shares of its common stock at $.13 per share to replace
the option included in the promissory note on substantially similar terms as the option.
In August 2007, the Company entered into stock purchase agreements with certain members of the
Board of Directors. The directors issued notes to the Company in exchange for their stock
purchases. See Note 7 for further discussion. These notes are recorded as notes receivable in
Stockholders Deficit.
The Company engages the law firm of Sauerwein, Simon and Blanchard (SSB) related to various
issues including our reverse merger, our SB-2 registration statement, litigation matters and
general business activity. A member of our board of directors is a partner of SSB. For the three
months ended March 31, 2008 and 2007, we incurred approximately $55,000 and $0, respectively, in
legal fees with SSB. As of March 31, 2008, all amounts have been paid to SSB except for
approximately $37,000.
The Company uses Arthur J. Gallagher (AJG) as its broker for business and property insurance. Our
CEOs brother is employed by AJG and is involved in the negotiation of coverage and premiums
related to policies placed for the Company. For the three months ended March 31, 2008, the Company
paid approximately $3,000 in commissions on policies placed by AJG. The Company placed no policies
and paid no commissions in 2007.
7
Table of Contents
Note 7 Share-based Payments
The Company accounts for stock options and restricted stock issued to employees and directors under
SFAS No. 123(R), in which share-based compensation cost to employees and directors is measured at
the grant date, based on the estimated fair value of the award, and is recognized as expense over
the requisite service period. The Company has no awards with market or performance conditions.
In March 2007, the Company adopted the 2007 Stock Option Plan (Stock Plan) for its employees,
officers, directors and consultants, which includes an equity compensation plan for non-employee
directors pursuant to which stock options and shares of restricted stock may be granted.. The
Company has reserved a maximum of 7,000,000 shares of common stock to be issued for the exercise of
options or shares awarded under the Stock Plan. A proposal to increase the maximum share amount to
9,000,000 is included for shareholder approval as part of the Companys Annual Stockholder Meeting
to be held on June 17, 2008.
In August 2007, the Company granted options to purchase an aggregate 3,850,000 shares of common
stock to various employees that vest ratably over three years and options to purchase an aggregate
160,000 shares of common stock to directors that vest ratably over two years. All options have an
exercise price of $0.15. The Company also issued an aggregate of 600,000 shares of restricted
common stock to our directors. Under the agreements, each director agreed to purchase 150,000
shares of common stock of the Company at a cost of $0.15 per share. The directors issued notes to
the Company in exchange for their stock purchases. The shares issued under the agreements are
restricted shares subject to a right, but not obligation, of repurchase by the Company. The
Company may exercise its repurchase right only during the 60 day period following a directors
termination of service on the Board of Directors. Commencing on September 21, 2007, the Companys
repurchase rights lapse at the rate of 8,333 shares per month of continuous service by each
director through September 21, 2008, when the Companys repurchase rights lapse on 4,167 shares per
month of continuous board service until the repurchase rights have lapsed on all restricted shares.
At March 31, 2008, 366,676 shares were subject to a right of repurchase. No options were cancelled,
expired or exercisable as of March 31, 2008.
Additionally, upon commissioning of the pilot plant, an option to purchase 1,200,000 shares of
common stock will be issued to our Chief Executive Officer. This option has not yet been granted,
but if and when granted, will vest ratably over three years beginning on August 31, 2009.
The estimated fair value of stock option grants is computed using the binomial option-pricing
model. Generally, expected volatility is based on historical periods commensurate with contractual
term of options. However, since we have no history of stock price volatility as a public company at
the time of the grants, we calculated volatility by considering historical volatilities of public
companies in our industry. Due to the short history of our industry, the historical period used in
our calculations is shorter than the contractual term of the options. The fair value for options
granted was estimated as of March 31, 2008 to be $0.78 per share assuming a contract term of 6.4
years, a risk-free interest rate of 2.9%, expected volatility of 46.3% and no expected dividends.
Stock option expense is recognized in the statements of operations ratably over the vesting period
based on the number of options that are expected to ultimately vest. We currently use a forfeiture
rate of zero percent for all existing share-based compensation awards since we have no historical
forfeiture experience under our share-based payment plans. Our options have characteristics
significantly different from those of traded options and changes in the assumptions can materially
affect the fair value estimates.
During the three months ended March 31, 2008, the Company recorded, as general and administrative
expenses, stock based compensation of approximately $550,000 for employee stock options and $36,000
for director stock options. No expense was recorded for the three months ended March 31, 2007 as
the Companys Stock Plan was adopted in March 2007 and grants were first made in August 2007.
Related to these grants, the Company will record future compensation expense for stock options of
approximately $480,000 for the remaining nine months of 2008.
The potential tax benefit realizable for the anticipated tax deductions of the exercise of
share-based payment arrangements totaled approximately $242,000 for the three months ended March
31, 2008. However, due to the uncertainty that the tax benefits will be realized, these potential
benefits were not recognized currently.
8
Table of Contents
As of March 31, 2008, there was approximately $2,510,000 of unrecognized compensation cost related
to 4,010,000 nonvested stock options that we expect to ultimately vest. These options have a
weighted average exercise price of $0.15. The unrecognized compensation cost is expected to be
recognized over a weighted-average period of 2.96 years.
Weighted | ||||||||
Shares Under | Average | |||||||
Option | Exercise Price | |||||||
Adoption of Stock Plan in March 2007 |
| |||||||
Granted |
4,010,000 | $ | 0.15 | |||||
Exercised |
| |||||||
Forfeited |
| |||||||
Options outstanding at December 31, 2007 |
4,010,000 | 0.15 | ||||||
Granted |
||||||||
Exercised |
| |||||||
Forfeited |
| |||||||
Options outstanding at March 31, 2008 |
4,010,000 | |||||||
Options exercisable at March 31, 2008 |
| |||||||
Pursuant to a settlement agreement, RAM Resources, L.L.C. obtained the right to acquire an
aggregate of 1,923,495 shares of our common stock at a price of $0.13 per share. This warrant is
exercisable during a two year term that started on August 29, 2007 and ends on August 29, 2009.
RAM Resources, L.L.C. agreed to terminate the Letter Agreement and release all claims to acquire
any shares of our stock. The fair value of $125,027 has been recorded in the Companys general and
administrative expenses for the year ended December 31, 2007 and additional paid in capital at
December 31, 2007.
Note 8 Commitments and Contingencies
Project management The Company entered into an engagement agreement with Merrick & Company to
develop a complete project management plan for the pilot development plan. For the three months
ended March 31, 2008, we incurred approximately $57,000 for engineering, design and consulting
services. After completing the project management plan, we engaged Merrick & Company to construct,
test, and evaluate the HFTA equipment and the demonstration plant. As part of the testing and
evaluation, Merrick & Company will provide construction observation of the demonstration unit in
conjunction with Hazen Research, Inc. The system will demonstrate the efficacy of using biomass
derived from municipal waste to produce ethanol using our licensed technologies and will allow us
to develop the engineering data to design and construct a small commercial plant. Our engagement
calls for further payments to Merrick & Company on an as billed basis as they proceed with the
engineering review and testing of our technology.
In December 2007, the Company entered into an agreement with Hazen Research, Inc. (Hazen) to
install and operate the HFTA equipment at Hazens facility in Golden, Colorado. The agreement also
contemplates the expansion of the scope of work to include the construction and operation of the
demonstration plant. We are billed at an hourly rate for time used by Hazen employees in
connection with our projects. We anticipate the costs of the proof of concept phase with Hazen
will be approximately $100,000, of which we incurred approximately $90,000 for the three months
ended March 31, 2008. We are currently working with Hazen to develop an estimate of the costs to
construct and operate the demonstration unit at their facility.
Leases We entered into a lease on October 16, 2007 (and took occupancy in January 2008) to rent
approximately 1,800 square feet of office space for use as our corporate office, located at 7386
Pershing Ave. in St. Louis, Missouri for a term of three years. Our monthly rent under the lease
is $1,800 plus the cost of utilities. We entered into a lease for office furniture in January 2008.
The lease payments are approximately $420 per month for 36 months. This lease is accounted for as a
capital lease for accounting purposes.
9
Table of Contents
Note 9 Subsequent Events
From April 8, 2008 through April 28, 2008, various debenture holders converted $630,000 of our
debentures, plus interest earned, into 4,455,844 shares of our common stock. Including those
debentures converted in March 2008, as disclosed in Note 4, as of May 9, 2008, $1,260,000 of the
debentures had been converted, leaving $140,000 of the debentures remaining to be converted.
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Statement Regarding Forward-Looking Information
From time to time, we make written or oral statements that are forward-looking, including statements contained in this report and other filings with the Securities and Exchange Commission (SEC) and in our reports to stockholders. The Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, provide a safe harbor for such forward-looking statements. All statements, other than statements of historical facts, included herein regarding our strategy, future operations, financial position, future revenues, projected costs, prospects, plans, objectives and other future events and circumstances are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as anticipates, believes, estimates, expects, intends, may, plans, projects, would, should and similar expressions or negative expressions of these terms. Such statements are only predictions and, accordingly, are subject to substantial risks, uncertainties and assumptions.
From time to time, we make written or oral statements that are forward-looking, including statements contained in this report and other filings with the Securities and Exchange Commission (SEC) and in our reports to stockholders. The Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, provide a safe harbor for such forward-looking statements. All statements, other than statements of historical facts, included herein regarding our strategy, future operations, financial position, future revenues, projected costs, prospects, plans, objectives and other future events and circumstances are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as anticipates, believes, estimates, expects, intends, may, plans, projects, would, should and similar expressions or negative expressions of these terms. Such statements are only predictions and, accordingly, are subject to substantial risks, uncertainties and assumptions.
Actual results or events could differ materially from the plans, intentions and expectations
disclosed in the forward-looking statements we make. We caution you that any forward-looking
statement reflects only our belief at the time the statement is made. Although we believe that the
expectations reflected in our forward-looking statements are reasonable, we cannot guarantee our
future results, levels of activity, performance or achievements. Refer to our Risk Factors section
of our annual report on Form 10-KSB for the year ended December 31, 2007, filed with the Securities
and Exchange Commission on March 28, 2008, for a full description of factors we believe could cause
actual results or events to differ materially from the forward-looking statements that we make.
These factors include:
| the commercial viability of our technologies, | ||
| our ability to maintain and enforce our exclusive rights to our technologies, | ||
| our ability to raise additional capital on favorable terms in the next one to two months, | ||
| our disputes and resulting litigation with the licensor of our PSC technology, | ||
| the demand for and production costs of ethanol, | ||
| competition from other alternative energy technologies, and | ||
| other risks and uncertainties detailed from time to time in our filings with the SEC. |
Although we believe the expectations reflected in our forward-looking statements are based upon
reasonable assumptions, it is not possible to foresee or identify all factors that could have a
material and negative impact on our future performance. The forward-looking statements in this
report are made on the basis of managements assumptions and analyses, as of the time the
statements are made, in light of their experience and perception of historical conditions, expected
future developments and other factors believed to be appropriate under the circumstances.
Company Overview
We are a development stage company that intends to:
| complete the research and development of our licensed technologies, which we believe when combined can convert municipal solid waste into ethanol; and | ||
| explore, develop and/or license additional technologies for processing waste into energy products as opportunities to do so present themselves. |
10
Table of Contents
Our licensed technologies are:
| the Pressurized Steam Classification technology, which we refer to as our PSC technology, invented at the University of Huntsville, Alabama, that uses a pressurized steam classification vessel to convert municipal solid waste, also known as MSW, into cellulosic material while simultaneously segregating and eliminating any inorganic materials in the solid waste and cleaning recyclable materials in the MSW; | ||
| the sulfuric acid hydrolysis process, which we refer to as our Brelsford technology, developed by Brelsford Engineering, Inc., that employs an acid hydrolysis process to convert cellulosic material into fermentable sugars, which can then be fermented into ethanol; and | ||
| the nitric acid hydrolysis process, which we refer to as our HFTA technology, developed by scientists working at the University of California, Berkeley, that incorporates anticipated improvements in chemical reaction by which acid hydrolysis occurs. |
We were originally incorporated in 1996 as Long Road Entertainment, Inc., and were formed to
operate as a holding company for businesses in the theater, motion picture and entertainment
industries. We ceased conducting that business in 2005 and were dormant until the fall of 2006, at
which time our founder and then controlling stockholder decided to pursue the sale of the company.
In anticipation of that sale, we changed our name to Alternative Ethanol Technologies, Inc.
On March 27, 2007, we entered into an Agreement and Plan of Merger and Reorganization in which we
agreed to acquire SRS Energy, Inc., a Delaware corporation (SRS Energy), which is the holder of
the technology licenses. Pursuant to the merger agreement, SRS Acquisition Sub Inc. our
wholly-owned subsidiary, merged into SRS Energy with SRS Energy as the surviving corporation. We
consummated the merger on May 31, 2007 resulting in SRS Energy becoming our wholly-owned
subsidiary. Today, SRS Energy is our principal operating company. Effective August 2, 2007, we
changed our name to CleanTech Biofuels, Inc.
SRS Energy was originally formed, in July 2004, as a wholly-owned subsidiary of Supercritical
Recovery Systems, Inc., a Delaware corporation. At that time, Supercritical Recovery Systems was a
licensee of various technologies for the processing of waste materials into usable products. While
investigating different technologies, Supercritical Recovery Systems, Inc. was introduced to the
PSC and Brelsford technologies and secured licenses to the technologies in SRS Energy. Prior to our
acquisition of SRS Energy, Supercritical Recovery Systems, Inc. distributed approximately 80% of
its ownership of SRS Energy to the stockholders of Supercritical Recovery Systems, Inc. Since our
acquisition of SRS Energy, Supercritical Recovery Systems, Inc. has ceased its business activities
with respect to licensing other technologies.
Plan of Operation/Results of Operations
The following discussion of our plan of operation should be read in conjunction with the financial
statements and related notes to the financial statements included elsewhere in this report. This
discussion contains forward-looking statements that relate to future events or our future financial
performance. These statements involve known and unknown risks, uncertainties and other factors that
may cause our actual results, levels of activity or performance to be materially different from any
future results, levels of activity or performance. These risks and other factors include, among
others, those listed under Statement Regarding Forward-Looking Information.
The license to the PSC technology grants SRS Energy limited exclusive rights to use the technology
to process municipal solid waste and convert the cellulosic component of that waste to a homogenous
feedstock to produce ethanol in the United States, subject to the right of Bio-Products to request
five sites to construct solid waste to ethanol plants in the United States. SRS Energys license to
the Brelsford technology is limited to the production of fuel grade ethanol in the United States.
The license is exclusive with regard to the conversion of MSW to cellulosic
biomass and non-exclusive with respect to the conversion of other feedstock for the production of
ethanol. The license to the HFTA technology provides us an exclusive worldwide license to use the
technology for the production of energy products from MSW and a non-exclusive license to use the
technology to produce energy products from other feedstocks. By coupling these technologies, we
believe we may have the ability to extract biomass from curbside solid waste (among other potential
sources of cellulosic material) and convert it into fuel grade ethanol.
11
Table of Contents
We have no operating history as a producer of ethanol and have not constructed any ethanol plants
to date. We have not earned any revenues to date and expect that our current capital and other
existing resources will be sufficient only to complete the testing of our technologies and to
provide a limited amount of working capital. We will require substantial additional capital to
implement our business plan and we may be unable to obtain the capital required to build any
commercial plants. Our strategy is to build our company in several phases with the ultimate goal of
becoming a leading producer of ethanol and other combustible fuels from municipal waste and other
feedstocks.
We are currently focusing on testing, demonstrating and commercializing our existing licensed
technologies. On an ongoing basis, we intend to continue investigating opportunities to develop or
acquire complementary technologies, especially those that would allow us to improve our existing
processes or to add value to the various byproducts produced by those processes. In addition, we
will look for opportunities to combine our technologies with other synergistic processes in
innovative energy parks, where some of our byproducts, such as lignin, could be used as inputs to
other processes, such as gasifiers, that could produce inputs for us, such as steam. We have
structured our Strategic Plan on the following three phases with respect to the development and
commercialization of our existing technologies:
Proof of Concept/Demonstration Phase
At this stage of our development we are seeking to prove that biomass derived using the PSC
technology does not include any contaminants or residue that prohibit the chemical or biologic
reactions necessary to complete the sacchrification and fermentation processes required to produce
fuel grade ethanol. We believe that the HFTA technology may prove useful as a pretreatment for a
variety of other hydrolysis technologies being developed to separate hemicelluloses and then using
commercially available enzymes to separate the remaining cellulose and lignin. In order to
determine whether this is true, we also are testing the HFTA equipment as a first-stage to separate
hemicellulose and then using commercially available enzymes to separate the cellulose. In addition
to using the HFTA technology for hydrolyzing biomass, we are also using the HFTA equipment to test
a variety of other feedstocks, including corn stover, switch grass and wood waste using these same
methods of hydrolyzing biomass. We believe the hydrolsate derived from these various processes and
feedstocks can be fermented into alcohol.
Concurrent with the proof of concept, we are completing the design and engineering of a
demonstration system that would incorporate all of our technology for sacchrification and
fermentation into a continuously operating unit. We project that this system will process
approximately four tons of MSW, or about one ton of dry biomass per operating day, which on average
is eight hours. The purpose of the unit is to demonstrate the complete system for converting
biomass derived from MSW into ethanol. Final details of the demonstration plant design will depend
on results of the proof of concept phase; however, we have substantially completed these designs
and believe we will be able to move to fabrication, procurement and construction of the
demonstration unit upon completing the proof of concept testing provided we are able to obtain the
financing necessary to do so. After completing construction of the demonstration plant, we intend
to operate the plant for a period of time, currently anticipated to be two to three months, in
order to conduct testing and evaluation necessary to complete the design of a small commercial
plant. While we have not yet completed the project management plan for the demonstration phase of
the project, we anticipate this phase of the project will require nine to twelve months following
the end of the testing phase to complete.
Commercialization Phase
Before we attempt to implement our technology on a larger scale, we anticipate building and
operating a small commercial plant that will process a minimum of 100 tons of MSW per operating
day. The final size of this small scale commercial plant will be determined based on a number of
factors that we are currently evaluating. The purpose of building a small scale commercial plant
is to demonstrate at a small commercial level the workings of the integrated system, including the
PSC technology, in order to have sufficient information with respect to materials
handling and operation of the technology to enable us to utilize more traditional project financing
for the implementation of the technology on a larger scale.
12
Table of Contents
Replication and Rollout Phase
We intend to follow a systematic evaluation process in identifying and selecting additional sites
for the construction of full-scale operating plants in order to focus on those with the best
near-term and long-term potential. If market conditions are not favorable for the construction of
new plants, we may consider licensing our technology to third parties with existing waste-to-energy
facilities. To date, we have not identified any sites for a full-scale facility or commenced any
material discussions with any party regarding building a full-scale operating plant and/or
licensing our technology to a third-party. We have only preliminarily begun to explore these
possibilities.
Our ability to implement this strategy will depend on our ability to raise significant amounts of
additional capital and to hire appropriate managers and staff. Our success will also depend on a
variety of market forces and other developments beyond our control. The following table sets forth
the amounts of expenses and percentages of expenses represented by certain items reflected in our
consolidated statements of operations for the three months ended March 31, 2008 and 2007:
Three months ended | Three months ended | |||||||||||||||
March 31, 2008 | March 31, 2007 | |||||||||||||||
Costs and expenses: |
||||||||||||||||
General and administrative |
$ | 649,462 | 68.8 | % | $ | 4,007 | 67.0 | % | ||||||||
Professional fees |
111,946 | 11.9 | % | 1,970 | 33.0 | % | ||||||||||
Research and development |
183,104 | 19.4 | % | | 0.0 | % | ||||||||||
944,512 | 100.0 | % | 5,977 | 100.0 | % | |||||||||||
Other expense (income): |
||||||||||||||||
Interest |
19,751 | 3,597 | ||||||||||||||
Amortization of technology license |
3,750 | | ||||||||||||||
Interest income |
(5,727 | ) | | |||||||||||||
Net loss applicable to common stockholders |
$ | 962,286 | $ | 9,574 | ||||||||||||
Three months ended March 31, 2008 compared to the three months ended March 31, 2007
General
Prior to April 2007, we had limited operations. In April 2007, we raised $1,400,000 and commenced
implementing our plan of operation. As a result, our increased operating activities and the
issuance of options (and the resulting expense in accordance with FAS 123R) are the primary reasons
we experienced significant increases in our costs and expenses when comparing the three months
ended March 31, 2008 with the three months ended March 31, 2007. In particular, we experienced the
following specific changes in our operations:
Costs and expenses:
General and administrative The increase in 2008 is due primarily to recording approximately
$585,000 in share-based compensation expense (FAS 123R), salary paid to our Chief Executive Officer
and expenses for our office lease and related expenses which commenced in January 2008.
Professional fees The increase in 2008 is due to increased costs incurred for legal, consulting
and accounting fees related to various filings with the Securities and Exchange Commission (as we
became a reporting company in January 2008), litigation matters and an increase in general business
activities.
Research and development The increase in 2008 is due to payments made to Merrick & Company, Hazen
Research, Inc. and HFTA as commencement of our proof of concept/demonstration phase began during
the third quarter 2007. All parties are involved in the testing, evaluation, design and
construction of our proof of concept / demonstration phase and commercialization phase of our
technologies.
13
Table of Contents
Other expense (income):
Interest expense The increase in 2008 is due primarily to the issuance in April 2007 of the
Series A Convertible Debentures, which accrue interest at 6.0% per annum. Interest on the
debentures for the three month ended March 31, 2008 is approximately $19,000.
Amortization of technology license As the proof of concept/demonstration phase began during the
third quarter 2007 we have begun to amortize the technology license fees previously capitalized.
Interest income The income in 2008 is primarily interest on $450,000 of promissory notes issued
to us as part of the consideration for the issuance of the Series A Convertible Debentures. We
received the $450,000 plus accrued interest on March 14, 2008.
Liquidity and Capital Resources
As a development-stage company, we have no revenues and will be required to raise additional
capital in order to execute our business plan and commercialize our products.
We expect our current cash will be sufficient to fund the next one to two months of our plan of
operation. Thereafter, we anticipate requiring additional capital to complete the demonstration and
commercialization phases of our plan of operation. These costs will be substantially greater than
our current available funds. We currently expect attempting to obtain additional financing through
the sale of additional equity and/or possibly through strategic alliances with larger energy or
waste management companies. However, we may not be successful in securing additional capital. If we
are not able to obtain additional financing in the near-term future, we will be required to delay
our development until such financing becomes available. We anticipate that the current dispute with
Bio-Products will make it significantly more difficult for us to raise capital. Further, even
assuming that we secure additional funds, we may never achieve profitability or positive cash flow.
If we are not able to timely and successfully raise additional capital and/or achieve profitability
or positive cash flow, we will not have sufficient capital resources to implement our business
plan.
Off-Balance Sheet Arrangements
There are no off-balance sheet arrangements.
Critical Accounting Policies
We prepare our consolidated financial statements in accordance with accounting principles generally
accepted in the United States of America. Certain accounting issues require management estimates
and judgments for the preparation of financial statements. Our management periodically evaluates
the estimates and judgments made. Management bases its estimates and judgments on historical
experience and on various factors that are believed to be reasonable under the circumstances.
Actual results may differ from these estimates as a result of different assumptions or conditions.
We believe that the estimates, assumptions and judgments relating to research and development
costs, share-based compensation and income tax matters have the greatest potential impact on our
financial statements. Therefore, we consider these to be our critical accounting estimates. Our
critical accounting policies and estimates are more fully described in our annual report on Form
10-KSB for the year ended December 31, 2007, filed with the Securities and Exchange Commission on
March 28, 2008. Our critical accounting policies and estimate assumptions have not changed during
2008.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
None.
14
Table of Contents
Item 4T. Controls and Procedures
Effectiveness of Disclosure Controls and Procedures We maintain a set of disclosure
controls and procedures designed to ensure that information required to be disclosed in our reports
filed under the Securities Exchange Act of 1934, as amended (the Act), is recorded, processed,
summarized and reported within the time periods specified by the Security and Exchange Commissions
(the SEC) rules and regulations. Disclosure controls are also designed with the objective of
ensuring that this information is accumulated and communicated to our management, including our
chief executive officer and chief financial officer, as appropriate, to allow timely decisions
regarding required disclosure.
Our management does not expect that our disclosure controls and procedures will necessarily prevent
all fraud and material error. Our disclosure controls and procedures are designed to provide
reasonable assurance of achieving the objectives outlined above. Based on their most recent
evaluation, our chief executive officer and chief financial officer concluded that our disclosure
controls and procedures are effective at that reasonable assurance level at March 31, 2008.
Further, the design of a control system must reflect the fact that there are resource constraints,
including, but not limited to having three total employees (chief executive officer, general
counsel and chief financial officer), and the benefits of controls must be considered relative to
their costs. Because of the inherent limitations in all control systems, no evaluation of controls
can provide absolute assurance that all control issues and instances of fraud, if any, within the
Company have been detected. These inherent limitations include the realities that judgments in
decision-making can be faulty, and that breakdowns can occur because of simple error or mistake.
Changes in Internal Control Over Financial Reporting During the three months ended March
31, 2008, there were no material changes in the Companys internal control over financial reporting
that have materially affected, or are reasonably likely to materially affect, the Companys
internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
CleanTech Biofuels, Inc. v. Bioproducts International, Inc. On January 9, 2008, CleanTech
Biofuels, Inc. and our wholly-owned subsidiary, SRS Energy, Inc. (SRS Energy), filed suit in
Missouri Circuit Court seeking damages against Bio-Products, the licensor of our PSC technology,
Clean Earth Solutions, Inc., which we believe to be an affiliate of Bio-Products (CES), and
various shareholders and officers of those companies for, among other things, fraudulent acts,
civil conspiracies, and tortuous interference with our business. We also are seeking to rescind a
sublicense with respect to the use of the PSC technology in five sites that we granted back to
Bio-Products. The case has been subsequently moved to the Federal District Court in St. Louis,
Missouri.
In addition, we have filed a demand for arbitration seeking, among other things, a declaration that
we are in full compliance with the terms of the License Agreement between SRS Energy and
Bio-Products dated August 17, 2005 (the License Agreement). We filed the arbitration demand in
response to what we believe was a baseless attempt by Bio-Products to terminate the License
Agreement in violation of the terms of the License Agreement and are seeking damages against
Bio-Products for its fraudulent attempt to terminate the License Agreement. The American
Arbitration Association has determined that the arbitration will occur in St. Louis. In early
April, an arbitrator was selected to hear this matter. We anticipate that the arbitration will
occur in September 2008, at the earliest. On May 8, 2008, we filed a Temporary Restraining Order in
the Arbitration seeking to require Bio-Products to provide us with biomass for testing purposes as
required in the License Agreement.
If we are
not successful in our arbitration and lawsuit, that failure could
have a materially adverse effect on our business. See the Risk Factors
and previous disclosure of this legal proceeding in our Annual Report
on Form 10-KSB for the year ended December 31, 2007, filed with the
Securities and Exchange Commission on March 28, 2008, and our
Form 8-K filed with the Securities and Exchange Commission on
January 10, 2008, all of which is incorporated by reference
herein.
Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the
risk factors discussed in Part II, Item 6 in our Annual Report on Form 10-KSB for the year ended
December 31, 2007, which could materially affect our business, financial condition or future
results. These cautionary statements are to be used as a reference in connection with any
forward-looking statements. The factors, risks and uncertainties identified in these cautionary
statements are in addition to those contained in any other cautionary statements, written or oral,
which may be made or otherwise addressed in connection with a forward-looking statement or
contained in any of our subsequent filings with the Securities and Exchange Commission.
15
Table of Contents
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds None.
Item 3. Defaults Upon Senior Securities None.
Item 4. Submission of Matters to a Vote of Security Holders None.
Item 5. Other Information None.
Item 6. Exhibits
(a) The following documents are filed as a part of this Report.
EXHIBIT NO. | DESCRIPTION | |||
31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the
Securities Exchange Act, as amended. |
|||
31.2 | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of
the Securities Exchange Act, as amended. |
|||
32.1 | Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002) of Chief Executive Officer. |
|||
32.2 | Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002) of Principal Financial Officer. |
16
Table of Contents
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.
CLEANTECH BIOFUELS, INC. |
||||
Date: May 15, 2008 | /s/ Edward P. Hennessey, Jr. | |||
Edward P. Hennessey, Jr. | ||||
Chief Executive Officer | ||||
Date: May 15, 2008 | /s/ Thomas Jennewein | |||
Thomas Jennewein | ||||
Chief Financial Officer and Principal Accounting Officer |
17
Table of Contents
EXHIBIT INDEX
EXHIBIT NO. | DESCRIPTION | |||
31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the
Securities Exchange Act, as amended. |
|||
31.2 | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of
the Securities Exchange Act, as amended. |
|||
32.1 | Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002) of Chief Executive Officer. |
|||
32.2 | Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002) of Principal Financial Officer. |
18